Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
November 15, 2023
During the COVID-19 pandemic, whole genomic sequencing (WGS)-based surveillance played a key role in identifying variants of concern, investigating their spread and transmissibility, and facilitating the design and optimization of medical countermeasures, including diagnostic tools and vaccines. How...
Blog Post
November 15, 2023
On 1st October, the EU soft launched its Carbon Border Adjustment Mechanism (CBAM), which aims to help avoid “carbon leakage”, where companies move their production to country with less stringent climate policies. Reporting requirements will start from 2024 and full charges will come into effect in ...
Blog Post
September 14, 2023
COVID-19 is fading from public discussion, countries’ , and hopes for a safer and fairer future are being dashed by potentially watered-down political commitments. Yet people around the world continue to feel the impacts of COVID-19 every day, other infectious disease threats have not magically gone...
Multimedia
September 12, 2023
The first of CGD's conversations with candidates for the presidency of the European Investment Bank was with Margrethe Vestager. Margrethe is the Executive Vice-President of the European Commission and Commissioner for Competition. She has had a long and illustrious political career, having become a...
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...